ETV4 and prostate cancer: ETV4 was found medium-high expression in prostate cancer, breast cancer, non-small cell lung cancer and digestive tract cancer, including oral cancer, esophageal cancer, gastric and colorectal cancer, and was negatively correlated with patient prognosis and survival10-13.